Delivery Order 36C10G24D0059-36C10G25F0019
- Not listed
- Foundation Medicine, Inc., a molecular diagnostics company specializing in comprehensive genomic profiling and precision oncology testing, has been awarded a delivery order to fund the minimum guaranteed amount under a larger Indefinite Delivery Contract with the Department of Veterans Affairs Headquarters. The task order, valued at $2,500, represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2026. This award utilizes no set-aside provisions and will...
- This federal contract award to Foundation Medicine, Inc. is for the provision of genomic sequencing testing services, primarily to support the Department of Veterans Affairs' (VA) precision oncology initiatives. The contract, valued at $22,374,867.41, is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 2, 2024. Foundation Medicine, a leading provider of genomic profiling and molecular analysis services, has received multiple contracts from the VA...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $2,606.32 firm fixed price delivery order contract to Foundation Medicine, Inc. for hematologic malignancies next generation sequencing services. Under this contract, Foundation Medicine will provide genomic profiling and analysis of hematologic cancers to support the VA VHA's precision oncology initiatives. As a leading provider of comprehensive genomic profiling to guide cancer...
- The Department of Veterans Affairs awarded a $22.4 million delivery order contract to Foundation Medicine, Inc. for genomic sequencing testing services. The one-year firm fixed price contract will support VA's genomic medicine program by providing testing to help personalize cancer treatment for veterans. Performance will take place in Fredericksburg, Virginia. No subcontractors or set aside designations were identified. This delivery order was issued against an existing VA...
- The Department of Veterans Affairs Headquarters awarded Foundation Medicine, Inc. a $6.7 million firm fixed price delivery order for genomic sequencing testing services under an unspecified governmentwide acquisition contract vehicle. The contract calls for Foundation Medicine to provide genomic sequencing testing services in support of VA programs at its place of performance in Durham, North Carolina through September 2019. No subcontractors or set aside designations were identified. The...
- The Department of Veterans Affairs awarded Foundation Medicine, Inc. a $111.5 million firm fixed price delivery order against an unspecified contract vehicle to provide genomic sequencing testing services for the agency's minimum guarantee. This initial task order supports the VA's genomic sequencing program and will see Foundation Medicine conduct initial genomic testing from its laboratories in Cambridge, Massachusetts through January 2020. No subcontractors or set aside designations were...
- This is a task order awarded by the Department of Veterans Affairs (VA) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services to support precision medicine initiatives. The $24,000,010.00 firm fixed price contract is for the delivery of comprehensive genomic profiling for solid tumors and hematologic malignancies, next-generation sequencing panels, and molecular analysis to support the VA's National Precision Oncology Program. This contract is part...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services for precision oncology. The $110,000.00 contract is for next-generation sequencing (NGS) testing services to support the VA's hematologic malignancy programs. It has an ultimate completion date of July 31, 2026. This award is part of a larger $130.7 million Indefinite Delivery Contract (IDC) that...
- The Department of Veterans Affairs awarded a $17.7 million firm fixed price delivery order to Foundation Medicine, Inc. for genomic sequencing testing services. This order was issued against an unspecified government-wide acquisition contract vehicle to provide genomic sequencing testing to support the VA's healthcare programs. Foundation Medicine will perform the testing services out of its laboratory in Durham, North Carolina through September 2020. The funding agency, the VA Headquarters,...
- The Department of Veterans Affairs awarded a $22.2 million delivery order to Foundation Medicine, Inc. for genomic sequencing testing services. The firm fixed price order was issued against an unspecified governmentwide acquisition contract vehicle and will provide genomic sequencing to support the VA's healthcare programs. Foundation Medicine will deliver the testing services from its location in Durham, North Carolina over the one year period of performance beginning October 2020. No...
- 36C10G24D0059Indefinite Delivery Contract
- 36C10G24D0059-36C10G25F0019Delivery Order
Foundation Medicine, Inc. has been awarded a delivery order modification under a larger Indefinite Delivery Contract with the Department of Veterans Affairs (VA) Headquarters for comprehensive genomic profiling and precision oncology testing services. The modification adds an additional point of contact for Foundation Medicine International (FMI) and incorporates additional reporting requirements. This is part of the VA's National Precision Oncology Program, which utilizes next-generation sequencing (NGS) and comprehensive genomic profiling to support precision cancer diagnosis and treatment selection for veterans. The parent IDC carries a ceiling value of $130.7 million and extends through September 2028, with no set-aside provisions applied. The contract is structured as firm fixed price and includes performance at the contractor's facility in Durham, North Carolina. Under this agreement, Foundation Medicine, Inc. delivers advanced molecular diagnostics and genomic sequencing analysis services, including testing for both solid and hematological malignancies, with a requirement to analyze a minimum of 5,000 tumor samples annually. As a leading molecular diagnostics company based in Cambridge, Massachusetts, Foundation Medicine brings specialized expertise in precision oncology to the VA's veteran population across multiple Veterans Integrated Service Networks nationwide. The modification reflects the expanding scope and operational requirements of the VA's precision medicine initiatives, enabling enhanced coordination through the additional FMI point of contact and improved reporting mechanisms to support clinical decision-making in cancer treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($3m) | 12/8/25 | |
| P00001 | Other Administrative Action | $0 | 10/23/25 | |
| Not listed | Not listed | $24.7m | 9/29/25 |